Home/Apheon Bioscience/William J. Belden, Ph.D.

WJ

William J. Belden, Ph.D.

President, CSO

Apheon Bioscience

Therapeutic Areas

Oncology Women's Health

Apheon Bioscience Pipeline

Drug	Indication	Phase
Undisclosed Immunotherapy	Triple-Negative Breast Cancer (TNBC)	Preclinical

Leadership Team at Apheon Bioscience

Tammy M. Joska, Ph.D.

Co-founder, Advisor, Board Member

View full Apheon Bioscience profile